Why the study?
Does mastectomy, adjuvant radiation, or chemotherapy improve survival or RFS in patients with primary and secondary breast angiosarcoma?
Does mastectomy, adjuvant radiation, or chemotherapy improve survival or RFS in patients with primary and secondary breast angiosarcoma?
In breast angiosarcoma, tumor size and grade predict survival, mastectomy offers no survival benefit over breast-conserving surgery, and adjuvant radiation improves recurrence-free survival.
Answers are grounded in this paper and cite their sources.
Supports radiation after BCS in breast angiosarcoma; extends size/grade prognosis while leaving chemotherapy role open.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Abdou et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: